Interleukin-12p40 variants with improved stability

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/54 (2006.01) A61K 38/20 (2006.01) C12N 5/00 (2006.01) C12N 15/24 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2635618

Modified interleukin-12 (IL-12) p40 polypeptides are disclosed. The modified polypeptides have alterations in the IL-12p40 subunit to eliminate the protease site between positions Lys260 and Arg261. The modified IL-12p40 polypeptides according to the invention have improved stability compared to wild-type mature human IL-12p40 polypeptides.

La présente invention concerne des polypeptides p40 de l'interleukine 12 (IL-12) modifiés. Les polypeptides modifiés présentent des altérations de la sous-unité IL-12p40 afin d'éliminer le site de la protéase entre les positions Lys260 et Arg261. Les polypeptides IL-12p40 modifiés selon l'invention ont une stabilité améliorée comparée aux polypeptides IL-12p40 humains matures de type sauvage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interleukin-12p40 variants with improved stability does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-12p40 variants with improved stability, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-12p40 variants with improved stability will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1799416

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.